跳至主要内容
临床试验/NCT05173779
NCT05173779尚未招募不适用

A Single-arm Study to Evaluate the Efficacy and Safety of Left Atrial Isolation Achieved by Catheter Ablation in Patients With Persistent Atrial Fibrillation and Severe Atrial Fibrosis: a Chinese Registry Study

Shanghai Chest Hospital0 个研究点目标入组 50 人开始时间: 2023年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
50
主要终点
Postoperative atrial fibrillation (AF)/atrial flutter (AFL)/atrial tachycardia (AT) recurrence rate

研究概览

简要总结

This is a single-arm clinical trial evaluating the efficacy and safety of left atrial isolation achieved by catheter ablation in patients with persistent atrial fibrillation with severe atrial fibrosis.

详细描述

This is a single-arm clinical trial. Patients with persistent atrial fibrillation with severe atrial fibrosis are enrolled as subjects to conduct left atrial isolation by catheter ablation. Postoperative recurrence rate and other indicators are analyzed to evaluate the efficacy and safety of left atrial isolation achieved by catheter ablation in patients with persistent atrial fibrillation with severe atrial fibrosis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18 to 80 years old
  • Persistent AF with severe atrial fibrosis and left atrial anterioposterior diameter > 50mm
  • Nonresponse or intolerance to ≥1 antiarrhythmic drug
  • CHA2DS2-VASc ≥ 3 and HAS-BLED < 3

排除标准

  • With uncontrolled congestive heart failure;
  • Having significant valvular disease;
  • Having moderate-to-severe pulmonary hypertension;
  • With myocardial infarction or stroke within 6 months of screening;
  • With Significant congenital heart disease;
  • Ejection fraction was <40% measured by echocardiography;
  • Allergic to contrast media;
  • Contraindication to anticoagulation medications;
  • Severe pulmonary disease e.g. restrictive pulmonary disease, chronic obstructive disease (COPD);
  • Left atrial thrombus;
  • Having any contraindication to right or left sided heart catheterization

结局指标

主要结局

Postoperative atrial fibrillation (AF)/atrial flutter (AFL)/atrial tachycardia (AT) recurrence rate

时间窗: up to 18 months after enrollment

AF/AFL/AT recurrence is defined as presence of documented AF/AFL/AT episodes of 30 seconds or longer duration

次要结局

  • Postoperative AFL/AT rate(up to 18 months after enrollment)
  • Postoperative AF recurrence rate(up to 18 months after enrollment)
  • Incidence of complications(up to 18 months after enrollment)
  • Changes in the diameter of the left atrium and the left ventricular ejection fraction(up to 18 months after enrollment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xu Liu

Professor, deputy director of cardiology department of Shanghai Chest Hospital

Shanghai Chest Hospital

相似试验